期刊文献+

HPLC法测定长春西汀注射液的有关物质 被引量:1

Determination of Related Substances in Vinpocetine Injection by HPLC
下载PDF
导出
摘要 目的:建立测定长春西汀注射液有关物质的方法。方法:采用高效液相色谱法。色谱柱Inert Sustain C_(18)(250 mm×4.6 mm,5μm),检测波长:280 nm;流动相:0.2 mol·L^(-1)醋酸铵溶液-乙腈(40∶60),流速:1.0 ml·min^(-1);柱温:30℃,进样量:10μl。结果:长春西汀主峰与各杂质峰均能良好的分离。杂质A、B、C和D分别在0.276~5.520,0.283~5.660,0.269~5.380,0.282~5.640μg·ml^(-1)浓度范围内具有良好的线性关系,r分别为1.000 0,1.000 0,0.999 9,0.999 9。平均回收率分别为100.5%,100.7%,100.04%,99.9%(RSD分别为1.35%,0.99%,1.13%,1.10%,n=9)。结论:该方法具有较高的专属性、灵敏度、和精密度,能够有效控制长春西汀注射液中的有关物质。 Objective: To establish a method for the determination of related substances in vinpocetine injection. Methods: An HPLC method was adopted. An InertSustain C18(250 mm×4.6 mm,5μm) column was used with the mobile phase consisting of 0.2 mol·L^-1 ammonium acetate solution-acetonitrile (40:60) at the flow rate of 1mol·L^-1 . The detection wavelength was 280 nm, the column temperature was 30℃ and the sample size was 10 p.]. Results: The separation of vinpocetine and its impurities was good. The impurity A ,B,C and D bad good linearity within the range of 0.276-5. 520, 0.283-5. 660, 0.269-5. 380 and 0. 282-5. 640μg·ml^-1, and the correlation coefficient was 1. 000 0,1. 000 0,0,999 9 and 0. 999 9, respectively. The average recovery was 100.52% , 100.73% ,100.04% and 99.90%, and RSD was 1.35% ,0.99% ,1.13% and 1.10%, respectively(n =9). Conclusion: The specificity, precision and sensitivity of the method all meet the requirements. It can be used for the determination of relative substances in vinpocetine injection.
出处 《中国药师》 CAS 2016年第11期2182-2185,共4页 China Pharmacist
关键词 长春西汀注射液 反相高效液相色谱法 有关物质 Vinpoeetine injection RP-HPLC Related substances
  • 相关文献

参考文献4

二级参考文献37

  • 1王祥.高效液相色谱法测定长春西汀(片)的含量及其有关物质的研究[J].药物分析杂志,1995,15(4):23-26. 被引量:15
  • 2陈娟,姬明丽.急性脑梗死患者血糖水平与梗死范围及预后的关系[J].新乡医学院学报,2006,23(3):276-277. 被引量:6
  • 3张同喜,张改芹.银杏达莫注射液治疗急性脑梗死61例临床观察[J].新乡医学院学报,2006,23(5):507-509. 被引量:16
  • 4中华神经科学会.脑血管疾病分类、诊断要点及附件[J].中华神经科杂志,1996,29(6):376.
  • 5Vas A, Gulyas B. Eburnamine derivatives and the brain [J]. Med Res Rev, 2005, 25(6): 737-757.
  • 6Jeon K I, Xu X, Aizawa T, et al. Vinpocetine inhibits NF-r.B-dependent inflammation via an IKK-dependent but PDE-independent mechanism [J]. PNAS, 2010, 107(21): 9795-9800.
  • 7Medina A E. Vinpocetine as a potent anti-inflammatory agent [J]. PNAS, 2010, 107(22): 9921-9922.
  • 8Zhou X, Dong X, Crona J, et al. Vinpocetine is a potent blocker of rat Na-l. 8 Tetrodotoxin-resistant Sodium channels [J]. J Pharmacol Exp Therap, 2003, 306: 498-504.
  • 9Erdo S L, Molnar P, Lakics V, et al. Vincamine and vincanol are potent blockers of voltage-gated Na- channels [J]. EurJPharmacol, 1996, 314: 69,73.
  • 10Bonoczk P, Gulyas B, Adam-Vizi V, et al. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine [J]. Brain Res Bull, 2000, 53(3): 245-254.

共引文献46

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部